Related Experiment Video
Updated: Jun 27, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Standards for the management of sickle cell disease in children
1Department of Haematology, King's College Hospital, London SE5 9RS, UK. moira.dick@kch.nhs.uk
Insights
Sickle cell disease (SCD) is England's most common genetic disorder. Newborn screening, implemented by 2006, aims to reduce early-life mortality from pneumococcal sepsis.
Area of Science:
- Genetics
- Pediatrics
- Public Health
Background:
- Sickle cell disease (SCD) is the most common genetic condition in England, with a birth prevalence of 1 in 2000.
- SCD causes significant morbidity and mortality, especially in early childhood, without prophylactic measures.
- Newborn screening for SCD was introduced nationwide in England by 2006.
Purpose of the Study:
- To provide evidence-based treatment guidelines for children with sickle cell disease.
- To establish a management plan for healthcare professionals in low-prevalence areas.
- To support the national newborn screening program for sickle cell disease.
Main Methods:
- Review of existing evidence for sickle cell disease treatment.
- Consensus building on current best practices for SCD management.
- Development of standards and guidelines for pediatric SCD care.
Main Results:
- The article outlines the current evidence base for treating sickle cell disease.
- It presents a consensus on good practice for managing children with SCD.
- Guidelines are provided to support healthcare professionals, particularly in areas with limited resources.
Conclusions:
- Newborn screening for sickle cell disease is established in England and expanding to Scotland and Wales.
- Guidelines are crucial for managing SCD, especially in areas with lower prevalence and expertise.
- Further research is needed to enhance and refine existing treatment and care guidelines for SCD.
Abstract:
Sickle cell disease is now the commonest genetic condition in England with a birth prevalence of 1 in 2000. It causes significant morbidity and mortality particularly in the early years unless prophylactic measures have been put in place. By the end of 2006 newborn screening had been introduced all over England, its prime aim being to minimise mortality from pneumococcal sepsis in the first few years of life. Plans are currently underway to roll out programmes in Scotland and Wales. Standards and guidelines for the care of children with sickle cell disease were written to accompany the newborn screening programme and to offer a management plan for those working in areas of low prevalence where resources and expertise were possibly less well developed. This article describes the existing evidence base for treatment and the current consensus of good practice. It is acknowledged that more work needs to be carried out to develop guidelines further.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Kidney Transplant III: Nursing Management
Chronic Kidney Disease IV: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
